Histamine H1 and H4 receptor expression on the ocular surface of patients with chronic allergic conjunctival diseases

被引:14
作者
Inada, Noriko [1 ]
Shoji, Jun [1 ]
Shiraki, Yukiko [1 ]
Aso, Hiroshi [1 ]
Yamagami, Satoru [1 ]
机构
[1] Nihon Univ, Sch Med, Dept Visual Sci, Div Ophthalmol, Tokyo, Japan
关键词
Atopic keratoconjunctivitis; Histamine receptor; Ocular surface; Real-time RT-PCR; Vernal keratoconjunctivitis; VERNAL KERATOCONJUNCTIVITIS; ATOPIC-DERMATITIS; MESSENGER-RNA; H4; RECEPTORS; ANTIHISTAMINES; ANTAGONIST; TEARS; MODEL; MICE;
D O I
10.1016/j.alit.2017.03.004
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: This study investigated the histamine H-1 and H-4 receptors mRNA (H1R and H4R, respectively) expression on the ocular surface of patients with chronic forms of allergic conjunctival diseases to determine whether they can serve as biomarkers for allergic inflammation in the conjunctiva. Methods: We examined 19 patients with vernal or atopic keratoconjunctivitis (AKC/VKC group) and 15 healthy volunteers (control group). The AKC/VKC group was divided into active and stable stage subgroups. Specimens were obtained from the upper tarsal conjunctiva of each participant using a modified impression cytology method. H1R, H4R, and eotaxin-1, -2, and -3 mRNA (eotaxin-1, eotaxin-2, eotaxin-3, respectively) expression was determined by real-time RT-PCR. Immunohistochemical analysis for eosinophil cationic protein (ECP), eosinophil major basic protein (MBP), eotaxin-2, and histamine H4 receptor (H4R) were performed using conjunctival smears. Results: The number of H4R-positive patients was higher in the active than the stable stage subgroup and control group, whereas no difference was observed for H1R. H1R levels were higher in the active than in the stable stage subgroup, while those of H4R were higher in the active stage subgroup than in the control group. H1R and H4R levels were correlated with eotaxin-2 level. In immunohistochemical analysis, H4R revealed their expression on eosinophils in conjunctival smears of patients with AKC/VKC. Conclusions: H4R is useful as biomarkers of allergic inflammation on ocular surfaces. Most notably, H4R expressed on eosinophils is useful as a biomarker of eosinophilic inflammation of the ocular surface. Copyright (C) 2017, Japanese Society of Allergology. Production and hosting by Elsevier B.V.
引用
收藏
页码:586 / 593
页数:8
相关论文
共 19 条
[11]   The Role of Histamine H1 and H4 Receptors in Atopic Dermatitis: From Basic Research to Clinical Study [J].
Ohsawa, Yusuke ;
Hirasawa, Noriyasu .
ALLERGOLOGY INTERNATIONAL, 2014, 63 (04) :533-542
[12]   Histamine H4 receptor knockout mice display reduced inflammation in a chronic model of atopic dermatitis [J].
Rossbach, K. ;
Schaper, K. ;
Kloth, Ch. ;
Gutzmer, R. ;
Werfel, T. ;
Kietzmann, M. ;
Baeumer, W. .
ALLERGY, 2016, 71 (02) :189-197
[13]   Comparison of topical dexamethasone and topical FK506 treatment for the experimental allergic conjunctivitis model in Balb/c mice [J].
Shoji, J ;
Sakimoto, T ;
Muromoto, K ;
Inada, N ;
Sawa, M ;
Ra, CS .
JAPANESE JOURNAL OF OPHTHALMOLOGY, 2005, 49 (03) :205-210
[14]  
Shoji Jun, 2009, Allergology International, V58, P591, DOI 10.2332/allergolint.09-OA-0100
[15]   Evaluation of eotaxin-1,-2, and-3 protein production and messenger RNA expression in patients with vernal keratoconjunctivitis [J].
Shoji, Jun ;
Inada, Noriko ;
Sawa, Mitsuru .
JAPANESE JOURNAL OF OPHTHALMOLOGY, 2009, 53 (02) :92-99
[16]  
Takamura Etsuko, 2011, Allergology International, V60, P191, DOI 10.2332/allergolint.11-RAI-0335
[17]   Ophthalmic antihistamines and H1-H4 receptors [J].
Wade, Laurie ;
Bielory, Leonard ;
Rudner, Shara .
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 12 (05) :510-516
[18]   Histamine-stimulated cytokine secretion from human conjunctival epithelial cells:: Inhibition by the histamine H1 antagonist emedastine [J].
Weimer, LK ;
Gamache, DA ;
Yanni, JM .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1998, 115 (04) :288-293
[19]   The role of histamine H4 receptor in immune and inflammatory disorders [J].
Zampeli, E. ;
Tiligada, E. .
BRITISH JOURNAL OF PHARMACOLOGY, 2009, 157 (01) :24-33